Impact of the intestinal microbiota as a trigger of parkinson's disease
Keywords:
Microbiota, Parkinson's disease, inflammation, neurodegenerationAbstract
Years ago, it was believed that the gut microbiota only played a role in the digestion process. Today, it is known that it has a crucial impact on neurological health, to the extent that it has been associated with the development of Parkinson's disease. The objective of this research work is to analyze the role of the microbiota as a trigger for Parkinson's disease. This is a review of the literature related to gut microbiota and Parkinson's disease, which involved the collection and analysis of published bibliography over the last five years in both English and Spanish, yielding significantly relevant conclusions. Recent studies suggest that alterations in microbiota composition influence inflammation and metabolism, contributing factors to the progression of this disease. It is concluded that the bidirectional communication between the gut and the brain, known as the gut-brain axis, underscores the importance of microbiota in modulating the central nervous system, as it initiates systemic inflammatory processes that significantly influence the onset of Parkinson's disease.
Downloads
References
Almeida, C. C., Mendonça Pereira, B. F., Leandro, K. C., Costa, M. P., Spisso, B. F., y Conte-Junior, C. A. (2021). Bioactive compounds in infant formula and their effects on infant nutrition and health: A systematic literature review. International journal of food science, 2021(1), 8850080. https://doi.org/10.1155/2021/8850080
Aparicio Martínez, M. (2022). Papel de la dieta y la microbiota intestinal en la enfermedad de Parkinson. [Tesis de grado, Universidad de Valladolid]. https://uvadoc.uva.es/bitstream/handle/10324/54366/TFG-M-N2553.pdf?sequence=1&isAllowed=y
Bloem, B.R., Okun, M.S., Klein, C. (2021). Parkinson's disease. Lancet, 397(10291), 2284-2303. DOI: 10.1016/S0140-6736(21)00218-X
Cabrera Argudo, I. (2020). El papel de la inflamación intestinal en el desarrollo de enfermedades neurodegenerativas. [Tesis de pregrado, Universitas Miguel Hernández]. https://dspace.umh.es/bitstream/11000/8607/1/Cabrera%20Argudo%2c%20Isabel.pdf
Castelli, V., d'Angelo, M., Quintiliani, M., Benedetti, E., Cifone, M. G., y Cimini, A. (2021). The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?. Neural Regeneration Research, 16(4), 628-634. Doi: 10.4103/1673-5374.295270.
Castañeda Guillot, C. (2018). Actualización en prebióticos. Revista Cubana de Pediatría, 90(4), 1-16. http://scielo.sld.cu/pdf/ped/v90n4/1561-3119-ped-90-04-e648.pdf
Ccoyori Quispe, R. y Huahuatico Cano, V. (2022). Obtención de yogurt simbiótico liofilizado a diferentes temperaturas y porcentajes de jarabe de yacón (Smallanthus sonchifolius). [Tesis de grado, Universidad Nacional de San Antonio Abad del Cusco]. http://repositorio.unsaac.edu.pe/bitstream/handle/20.500.12918/6939/253T20220401_TC.pdf?sequence=1&isAllowed=y
Nunes Costa, H., Esteves, A.R., Empadinhas, N., y Morais Cardoso, S. (2023). Parkinson's disease: a multisystem disorder. Neuroscience Bulletin, 39(1), 113-124. Doi: 10.1007/s12264-022-00934-6
Campo, R.D., y Cobo J. (2022). Faecal microbiota trasplant: Current status and perspectives beyond Clostridioides difficile infection. Rev. Enfermedades infecciosas y microbiología clínica, 41(4), 203-205. DOI: 10.1016/j.eimce.2022.10.011
Díaz Romero, D. (2024). La enfermedad de Parkinson y la incertidumbre. Una mirada desde la Enfermería. I Jornada Científica Virtual de Salud Pública, TunaSalud2024. https://eventossaludpublica.sld.cu/index.php/sp/2024
El-Ahmady, S., Ibrahim, N., Farag, N., y Gabr, S. (2021). Apiaceae plants growing in the East: Centuries of healing traditions and culture. In Ethnopharmacology of Wild Plants (pp. 246-300). CRC Press. https://www.taylorfrancis.com/chapters/edit/10.1201/9781003052814-15/apiaceae-plants-growing-east-sherweit-el-ahmady-nehal-ibrahim-nermeen-farag-sara-gabr
Franco Lacato, A.O. (2023). Actividad física y su relación con el sistema inmune. Revista Cubana de Investigaciones Biomédicas, 42, e1158 https://revibiomedica.sld.cu/index.php/ibi/article/view/1158/1165
Gómez Eguílaz, M., Ramón Trapero, J.L., Pérez Martínez, L., y Blanco, J.R. (2019). El eje microbiota-intestino-cerebro y sus grandes proyecciones. Revista de Neurología. 68(03), 111-117. https://doi.org/10.33588/rn.6803.2018223
Hirayama, M., y Ohno, K. (2021). Parkinson’s Disease and Gut Microbiota. Annals of Nutrition and Metabolism, 77(2), 28-35. Doi: 10.1159/000518147.
Jagaran, K., y Singh, M. (2021). Nanomedicine for neurodegenerative disorders: Focus on Alzheimer's and Parkinson's diseases. International journal of molecular sciences, 22(16), 9082. https://doi.org/10.3390/ijms22169082
Lafebre-Jimbo, E.J., Asuma-Buñay, C.L., Peñafiel-Mendoza, J.S., y Lajones-Intriago, K.A. (2024). Incidencia de la enfermedad de Parkinson en Ecuador. Dominio de las Ciencias, 10(1), 170-186. https://www.studocu.com/pe/document/universidad-san-ignacio-de-loyola/anatomia-humano/incidenciadelaenfermedaddeparkinsonenecuador/108636992
Sonat Pınar, K., Bengü, A., y Aysun, U. (2022). Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system. Neurological Sciences, 43(3),1799-1807. https://doi.org/10.1007/s10072-021-05507-5
KleineBardenhorst, S., Cereda, E., Severgnini, M., Barichella, M., Pezzoli, G., Keshavarzian, A., Desideri, A., Pietrucci, D., Aho, V. T. E., Scheperjans, F., Hildebrand, F., Weis, S., Egert, M., Karch, A., Vital, M., y Rübsamen, N. (2023). Gut microbiotadysbiosis in Parkinson disease: A systematic review and pooled analysis. European Journal of Neurology, 30(11), 3581-3594. https://doi.org/10.1111/ene.15671
Xiao-Yi, K., Xiao-Han, Y., Li-Juan, X., Yu-Qing, Z., Li-Ping, Z., Yi, L., Shao-Fang, P., y Chun-Li, Z. (2021). Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation. Microb Cell Fact, 20(1), 98. DOI: https://doi.org/10.1186/s12934-021-01589-0
Leiva, A.M., Martínez-Sanguinetti, M.A., Troncoso-Pantoja, C., Nazar, G., Petermann-Rocha, F., y Celis-Morales, C. (2019). Chile lidera el ranking latinoamericano de prevalencia de enfermedad de Parkinson. Revista Médica de Chile, 147(4). http://dx.doi.org/10.4067/S0034-98872019000400535
Maldonado Cornejo, J. G., Pilla Almeida, C. N., Pérez Peña, C.E., Remache Arias, D. A., y Pinzón Bernal, M. Y. (2022). Control motor y alteraciones de la marcha en la enfermedad de Parkinson. Movimiento Científico, 17(2), 45-51. DOI: 10.33881/2011-7191.mct.17206
Maldonado Gomez, A.B-, Soruco Vera., V.M., Condori Salluco, N.F., y Merida Copa, J.B. (2023) Influencia de la microbiota intestinal en la enfermedad de Parkinson: revisión bibliográfica. Revista Peruana de Ciencias de la Salud, 5(3), 1-13. https://doi.org/10.37711/rpcs.2023.5.3.422
Marino, B.L.B., De Souza, L.R., Sousa, K., Ferreira, J. V., Padilha, E.C., Da Silva, C.H.T.P., Taft, C.A., Hage-Melim, L.I.S. (2020). Parkinson’s disease: a review from pathophysiology to treatment. Mini reviews in medicinal chemistry, 20(9), 754-767. https://doi.org/10.2174/1389557519666191104110908
Meza-Espinoza, J.P., De la Cruz-Arias, V.R., Enríquez-Ramírez, N., López-Obregón, J.C., Leal-Ugarte, E., y Picos-Cárdenas, V.J. (2023). Variantes genéticas asociadas con la enfermedad de Parkinson en población mexicana. Revista Médica UAS,13(4), 430-439.
https://hospital.uas.edu.mx/revmeduas/articulos/v13/n4/parkinson_ar.pdf
Miquel-Rio, L., Alarcón-Arís, D., Torres-López, M., Cóppola-Segovia, V., Pavia-Collado, R., Paz, V., Ruiz-Bronchal, E., Campa, L., Casal,C., Montefeltro, A., Vila, M., Artigas, F., Revilla, R., Bortolozzi, A. (2022). Human α-sy- nuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Transl Psychiatry, 12(1),79. DOI: 10.1038/s41398-022-01842-z.
Miralles Mesana, M. (2023). ¿Existe relación entre la microbiota intestinal y las enfermedades del aparato reproductor femenino?. [Trabajo de fin de curso, Universidad de las Illes Balears]. https://dspace.uib.es/xmlui/bitstream/handle/11201/165079/Miralles_Mesana_Maria.pdf?sequence=1
Nowak, J. M., Kopczyński, M., Friedman, A., Koziorowski, D., y Figura, M. (2022). Microbiota Dysbiosis in Parkinson Disease-In Search of a Biomarker. Biomedicines, 10(9), 2057. https://doi.org/10.3390/biomedicines10092057
Organización Mundial de la Salud. (2023). Enfermedad de Parkinson. https://www.who.int/es/news-room/fact-sheets/detail/parkinson-disease#
Orozco, J. L., Valderrama-Chaparro, J. A., Pinilla-Monsalve, G. D., Molina-Echeverry, M. I., Pérez Castaño, A. M., Ariza-Araújo, Y., Prada, S.I., y Takeuchi, Y. (2020). Parkinson’s disease prevalence, age distribution and staging in Colombia. Neurology international, 12(1), 8401. DOI: 10.4081/ni.2020.8401
Martínez Peláez, J.P., Ormaza Garate, B.P., y Pucha Aguinsaca, K.F. (2023). Relación de la microbiota intestinal con enfermedades autoinmunes. VIVE. Revista de Investigación en Salud, 6(16), 142-153. http://www.scielo.org.bo/pdf/vrs/v6n16/a11-142-153.pdf
Taype Ramos, J. A. (2023). Formulación de una bebida simbiótica funcional con granos de kéfir y jarabe de yacón. [Tesis de grado, Universidad Nacional Micaela Bastidas De Apurímac]. https://repositorio.unamba.edu.pe/bitstream/handle/UNAMBA/1349/T_139.pdf?sequence=1&isAllowed=y
Teleanu, R.I., Niculescu, A.G., Roza, E., Vladâcenco, O., Grumezescu, A. M., y Teleanu, D. M. (2022). Neurotransmitters—key factors in neurological and neurodegenerative disorders of the central nervous system. International journal of molecular sciences, 23(11), 5954. https://doi.org/10.3390/ijms23115954
Tolosa, E., Garrido, A., Scholz, S. W., y Poewe, W. (2021). Challenges in the diagnosis of Parkinson's disease. Lancet Neurology, 20(5), 385-397. Doi: 10.1016/S1474-4422(21)00030-2
Vascellari, S., Palmas, V., Melis, M., Pisanu, S., Cusano, R., Uva, P., Perra, D., Madau, V., Sarchioto, M., Oppo, V., Simola, N., Morelli, M., Santoru, M. L., Atzori, L., Melis, M., Cossu, G., y Manzin, A. (2020). Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease. MSystems, 5(5), e00561-20. https://doi.org/10.1128/mSystems.00561-20
Vázquez-Gómez, L.A. (2021). Deterioro cognitivo en pacientes con enfermedad de Parkinson. Acta Médica del Centro,15(2),1-8. http://scielo.sld.cu/pdf/amdc/v15n2/2709-7927-amdc-15-02-280.pdf
Weintraub, D., Aarsland, D., Chaudhuri, K. R., Dobkin, R. D., Leentjens, A. F., Rodriguez-Violante, M., y Schrag, A. (2022). The neuropsychiatry of Parkinson's disease: advances and challenges. Lancet Neurology, 21(1), 89-102. Doi: 10.1016/S1474-4422(21)00330-6
Published
Issue
Section
License
Copyright (c) 2025 Opuntia Brava

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




.png)



.png)



















